Search results for " industry 4.0"
Resource
Advancements in Antibody Purification
Join us November 19 and learn from industry experts on recent advancements and the future of antibody purification.
Article
Reimagining Affordable Biosimilars
Advances in preclinical development play a crucial role in reducing cost for developing biosimilars.
By Anurag S. Rathore, Narendra Chirmule, and Himanshu Malani
Drug development is …
Article
Testa Challenge 2020 Attracts Leading International Bioprocessing Innovators
Read more here >>
Six bioprocessing innovators have successfully completed the inaugural Testa Challenge 2020. Held over an intensive week in the Testa Center located at Cytiva´s Uppsala…
Article
Innovations in Cell Culture: Developing the Future
Join the discussion here >>
Thursday November 19, 2020 | 2:00 pm EST
Developing an upstream cell culture process is hard work. Join this discussion to explore the costs versus b…
Article
Advancements in Antibody Purification
Learn more and register here >>
The demand for more efficient and agile downstream purification processes for diversified therapeutic antibody pipelines requires the development of new…
Article
ISPE Releases Cleaning Validation Guide
ISPE has released new guidance on the cleaning validation lifecycle, written by a group of experts and reviewed by regulators and practitioners.
The International Society for Pharmaceutical Engin…
Article
Cytiva Introduces the Xcellerex Automated Perfusion System
The APS system comes equipped with filter switching, liquid management, and cell bleed to reduce risk of human error and increase process robustness.
Cytiva announced on Sept. 16, 2020 that it i…
Article
Platform for Purification of VHH-type Antibody Fragments
Click here to read this poster >>
Protein A affinity chromatography resins have been used to purify monoclonal antibodies (mAbs) by the bioprocess industry at all scales for a long time. Howev…
Article
Preparing for the Future Visions and Insights for Biomanufacturing
Click here to learn more >>
The biopharmaceutical industry has a reputation of being averse to change. Yet, new market dynamics, such as growing competition from biosimilars and niche drugs targe…
Article
Oligonucleotide Therapeutics Heading for Tons of Quantity in Annual Supply Need
Click here to read the full article >>
Solid-phase flow through technology poised to annually produce metric tons (1000 kg) provides the oligonucleotide therapeutic industry efficient synthesis t…